Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,650.00
Ask: 1,710.00
Change: 0.00 (0.00%)
Spread: 60.00 (3.636%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: GSK execs sell shares for tax bills, Airtel director makes £50k purchase

Thu, 17th Feb 2022 16:06

(Sharecast News) - GlaxoSmithKline disclosed a number of executive awards on Thursday, with two of its directors making large sales to cover their tax bills.

The FTSE 100 pharmaceuticals giant said chief executive officer Emma Walmsley had exercised nil-cost options granted in 2019 over 72,296 shares.

To meet her tax liabilities on that exercise, she then sold 34,031 shares for 1,609.97p each, totalling £547,888.92.

At the same time, GSK's chief scientific officer and president of research and development, Hal Barron, vested an annual bonus award granted in 2019 over 43,266 American depositary shares.

For his tax liabilities, he then sold 19,936 of those ADS securities for a price of $42.95432 each, the company disclosed.

On the buying side of things, Airtel Africa reported a share purchase made by one of its directors on Thursday, worth almost £50k.

The FTSE 100 mobile network operator said Ravi Rajagopal bought 35,750 shares on the London Stock Exchange on 10 February.

It said Rajagopal paid 139.8p for each share, spending a total of £49,978.50 in the process.

Top Director Buys

Schroder Uk Mid Cap Fund (SCP)

Director name: Page,Andrew

Amount purchased: 14,000 @ 616.70p

Value: £86,338.00

Airtel Africa (AAF)

Director name: Rajagopal,Ravi

Amount purchased: 35,750 @ 139.80p

Value: £49,978.50

Heiq (HEIQ)

Director name: Centonze,Carlo Riccardo

Amount purchased: 33,000 @ 90.00p

Value: £29,700.00

Watkin Jones (WJG)

Director name: Sergeant,Sarah

Amount purchased: 9,950 @ 247.63p

Value: £24,638.84

W H Ireland Group (WHI)

Director name: Wood,Tom

Amount purchased: 44,444 @ 45.00p

Value: £19,999.80

Aex Gold Inc. Npv (di) (AEXG)

Director name: Neuhauser,David Loren

Amount purchased: 43,300 @ $0.59

Value: $15,113.89

Aex Gold Inc. Npv (di) (AEXG)

Director name: Neuhauser,David Loren

Amount purchased: 17,200 @ $0.53

Value: $5,393.13

Aex Gold Inc. Npv (di) (AEXG)

Director name: Neuhauser,David Loren

Amount purchased: 14,000 @ $0.55

Value: $4,555.41

Aex Gold Inc. Npv (di) (AEXG)

Director name: Neuhauser,David Loren

Amount purchased: 10,300 @ $0.54

Value: $3,290.54

Aex Gold Inc. Npv (di) (AEXG)

Director name: Neuhauser,David Loren

Amount purchased: 7,000 @ $0.55

Value: $2,277.70

Johnson Matthey (JMAT)

Director name: MacLeod,Robert

Amount purchased: 18 @ 1,823.84p

Value: £328.29

Victrex Plc (VCT)

Director name: Court ,Martin

Amount purchased: 8 @ 1,979.00p

Value: £158.32

Top Director Sells

Glaxosmithkline (GSK)

Director name: Barron ,Hal

Amount sold: 39,872 @ $21.48

Value: $706,122.72

Glaxosmithkline (GSK)

Director name: Walmsley,Emma

Amount sold: 34,031 @ 1,609.97p

Value: £547,888.92

More News
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.